Carcinoid Heart Disease
📧 Sign up to get email alerts when something new happens for Carcinoid Heart Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: CardioNETPOL National Registry of Carcinoid Heart Disease
This entry describes the CardioNETPOL national registry for carcinoid heart disease, collecting data on patients with carcinoid heart diseas…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine Tumor [Phase 3]
Phase 3 trial update reports results for telotristat ethyl in treating carcinoid heart disease in patients with metastatic neuroendocrine tu…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Investigation of a Transcatheter Tricuspid Valved Stent Graft in Patients With Carcinoid Heart Disease [NA]
Clinical trial update for a transcatheter tricuspid valved stent graft in patients with carcinoid heart disease; the study is currently acti…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Development and Progression of Carcinoid Heart Disease in a Cohort of Adult Patients With Neuroendocrine Tumors
An ongoing observational cohort study by Hospices Civils de Lyon examining the development and progression of carcinoid heart disease in adu…
-
CLINICAL_TRIALS trial_result · 2020-08-04Clinical Trial Update: Carcinoid Heart Disease and Peptide Receptor Radiotargetted Therapy [Phase 2]
Phase 2 clinical trial update investigating peptide receptor radiotargeted therapy for carcinoid heart disease and carcinoid syndrome/tumor.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2020-02-05Clinical Trial Update: Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome [Phase 3]
Phase 3 trial of lanreotide with telotristat ethyl or placebo for first-line treatment in advanced well-differentiated small intestinal neur…